A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC
Clinical trial NCT03945604 · COMPLETED
Trial details
- NCT number
- NCT03945604
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2021-02-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.